INNV vs UNH
INNV: InnovAge provides comprehensive, capitated, all-inclusive healthcare for frail seniors through its network of PACE centers. UNH: A dominant, data-driven health care platform combining managed health benefits with integrated clinical and pharmacy services.
Side-by-side fundamentals
| Metric | INNV | UNH | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $9.15 | $419.26 | |
| Market cap | $1.2B | $376.3B | |
| P/E as of 2026-10-20 | n/a | 26.94 | |
| Net margin | -0.3% | +2.7% | UNH higher |
| Gross margin FY2026, SEC XBRL | +23.0% | n/a | |
| Operating margin | +0.3% | +4.2% | UNH higher |
| ROE | -1.1% | +12.0% | UNH higher |
| ROA | -0.5% | +3.9% | UNH higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | 0.20 | 0.70 | INNV lower |
| Revenue growth (YoY) | +15.9% | +11.8% | INNV higher |
| Revenue CAGR (3y) SEC XBRL | +12.9% | +11.4% | INNV higher |
| Dividend yield as of 2026-09-02 | n/a | +2.5% | |
| Dividend streak (yrs) SEC XBRL | 0 | 1 | UNH higher |
| Beta as of 2026-09-02 | 1.05 | 0.32 | |
| 1-year return as of 2026-10-20 close | +71.0% | +15.0% | INNV higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.